Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Has results × Fever × 1 year × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Breast Neoplasms 267 Carcinoma, Non-Small-Cell Lung 205 Neoplasms 188 Prostatic Neoplasms 155 Neoplasm Metastasis 120 Multiple Myeloma 119 Lung Neoplasms 102 Melanoma 100 Colorectal Neoplasms 99 Leukemia, Myeloid, Acute 98 Lymphoma 82 Ovarian Neoplasms 77 Lymphoma, Non-Hodgkin 70 Leukemia, Lymphocytic, Chronic, B-Cell 68 Pancreatic Neoplasms 65 Squamous Cell Carcinoma of Head and Neck 62 Hematologic Neoplasms 59 Myelodysplastic Syndromes 58 Precursor Cell Lymphoblastic Leukemia-Lymphoma 56 Glioblastoma 56 Triple Negative Breast Neoplasms 52 Parkinson Disease 4, Autosomal Dominant Lewy Body 52 Brain Neoplasms 52 Recurrence 50 Leukemia 50 Head and Neck Neoplasms 49 Lymphoma, Follicular 45 Carcinoma, Hepatocellular 45 Colonic Neoplasms 43 Urinary Bladder Neoplasms 41

Interventions

trametinib 1 dabrafenib 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT03551626 2025-04-29

COMBI-APlus

Novartis

Phase 3 Completed

552 enrolled 12 charts

Fever, Melanoma

Data powered by HemOnc (CC BY 4.0) Colophon ⚡